Sep 28, 2026 3-5pm ET
Monday on The Robert Scott Bell Show:

Hour 1
Death Rates For Young American Adults Jumped 71% In Just Over A Decade Death rates among Americans ages 25 to 44 increased 71.2% between 2010 and 2021, rising from approximately 140 deaths per 100,000 people to 239 per 100,000, according to an analysis by Virginia Commonwealth University physician and researcher Steven H. Woolf published in The Milbank Quarterly. The analysis draws on mortality data from the CDC, United Nations, OECD and U.S. Mortality Database and examines trends extending from 1999 through 2023. Drug overdoses were the largest contributor to worsening mortality among young adults, with the overdose death rate increasing roughly sevenfold since 1999, from about 7.7 to more than 54 deaths per 100,000, overtaking circulatory diseases as the leading cause of death in this age group in 2015. Suicide mortality among 25- to 44-year-olds increased more than 40% between 2000 and 2023, while homicide deaths increased 75.5% between 2014 and 2021 and transportation-related deaths rose 43.5%. The deterioration was not limited to injuries and substance use. Deaths involving diabetes and other endocrine and metabolic disorders increased nearly 25% between 2010 and 2019, deaths associated with alcohol-related liver disease more than doubled between 2010 and 2023, alcohol-related mental and behavioral disorder deaths more than tripled, and mortality attributed to hypertension more than doubled between 2000 and 2023. The analysis places these trends within a broader deterioration in America’s international health standing. By 2023, U.S. life expectancy ranked 38th among countries with populations exceeding one million, and 60 countries had lower probabilities of death before age 40 than the United States. Woolf identifies several potential contributors to the U.S. disadvantage, including healthcare access, poverty and income inequality, behavioral risks, the physical environment and differences in public policy compared with other wealthy nations. The paper also reports associations between state political leadership and mortality trends, particularly during COVID-19, but explicitly cautions that these observational relationships cannot establish that particular policies or political leadership caused the mortality differences because poverty, education, smoking, obesity and other factors vary considerably between states. The study is a narrative analysis of existing mortality records and published research rather than a controlled experiment, so its strongest conclusion is the scale and breadth of America’s mortality problem, not proof of a single cause. The striking 71.2% figure also specifically compares 2010 with the pandemic year of 2021 rather than describing a continuous 71% increase through 2023. Overall, Woolf argues that the simultaneous rise in overdose, suicide, injury and chronic-disease mortality among younger Americans reflects a broad public-health crisis that cannot be adequately explained by any one disease or risk factor.
Special Guests: Brian Festa
Brian Festa is a civil rights attorney who, along with his business partner and friend Dawn Jolly, founded We The Patriots USA to preserve and reclaim our God-given inalienable rights. With 15 years of experience working in state government, Brian has investigated, mediated, and prosecuted cases of discrimination in the workplace, housing, and places of public accommodation. Brian also conducted thousands of hearings as an appeals referee (administrative law judge) for the Connecticut Department of Labor prior to working as a civil rights attorney. He is admitted to practice law in the states of Connecticut and Idaho, the U.S. District Courts of Connecticut and Idaho, and the U.S. Supreme Court.
Brian is a father of two who first became involved in health freedom activism and legal work several years ago after his son was seriously injured by a vaccine, resulting in lifelong disabilities. Aside from managing the operations of We The Patriots USA, Brian travels throughout the nation to speak about the work of We The Patriots USA and what every American can do to protect our Constitutional rights. Brian has also been featured in various national print media and has appeared as a guest on dozens of broadcasts, including The Glenn Beck Program, The Charlie Kirk Show, The Steve Deace Show, Conservative Review with Daniel Horowitz, The Absolute Truth with Emerald Robinson, Steve Bannon’s War Room, One America News, Newsmax, Infowars with Alex Jones, and The Health Ranger Report with Mike Adams.
WTP USA Fighting to Restore Religious Exemptions for Schoolchildren Everywhere We The Patriots USA says it is pursuing federal litigation aimed at restoring religious exemptions from K-12 school
vaccinationrequirements in every state where such exemptions have been eliminated, identifying California, New York, Connecticut, and Maine as the four states that currently do not permit religious exemptions for required school vaccinations. The organization reports that it has a federal case pending before the Second Circuit that could affect families in Connecticut and New York, a separate federal lawsuit in California, and a lawsuit filed July 16, 2026, in Maine on behalf of a student who the organization says is being denied entry into eighth grade because of his religious objection to vaccination. We The Patriots USA views each case as a potential pathway to eventual U.S. Supreme Court review, with the broader objective of establishing nationwide precedent protecting religious objections to school vaccination mandates. Co-founder and Vice President Brian Festa argues that religious liberty should not vary according to the state in which a family lives and maintains that eliminating exemptions improperly places public-health policy above constitutionally protected religious rights. Festa also disputes the justification states have used for removing exemptions, asserting that there is insufficient evidence that religious exemptions have caused disease epidemics and arguing that families should not lose religious protections based on hypothetical future risks. The organization says it has committed to initiating litigation in every state that has eliminated religious exemptions and intends to pursue similar legal action if additional states remove them in the future. The campaign is part of We The Patriots USA’s broader legal work involving constitutional rights, and the organization is seeking donations to finance its existing cases, future lawsuits, educational programs, and related activities.

Welcome back to another “Homeopathic Hits” episode on The Robert Scott Bell Show!
Today’s Homeopathic Hit is Natrium Carbonicum, Carbonate of Sodium.
Boericke highlights this remedy for great debility from summer heat, chronic effects of sunstroke, exhaustion, weak digestion, oversensitivity to noise and weather changes, nasal catarrh, and weak ankles prone to sprains and dislocations.
Download the Information Sheet
Hour 2
Beware the mRNA Vaccine Pipeline Michael Bryant argues that the controversy surrounding HHS Secretary Robert F. Kennedy Jr.’s May 2026 PREP Act declaration should be viewed within a much larger expansion of mRNA vaccines and therapeutics involving pharmaceutical companies, governments, nonprofit organizations and major financial institutions. Kennedy’s declaration provides liability protection connected with favipiravir as a medical countermeasure for the Andes strain of hantavirus. Some MAHA and health-freedom activists criticized the decision because they want the COVID-19 PREP Act declaration rescinded and regard additional liability protections as potentially establishing a precedent for future countermeasures. Others argue Kennedy’s action is narrowly limited to one drug and one disease. Bryant places the disagreement alongside a 2024 PREP Act amendment covering bird-flu countermeasures and contends that these policies should be understood against the substantial investment occurring in next-generation medical technologies. He cites research identifying 557 registered clinical trials involving mRNA therapeutics, with 507, or about 91%, involving mRNA vaccines and approximately 93% of candidates still in Phase 0 through Phase II development. The pipeline encompasses infectious-disease vaccines as well as experimental applications involving melanoma, breast and lung cancers, glioblastoma and personalized cancer treatments. Bryant then focuses heavily on economics, citing market forecasts projecting continued growth in vaccines generally and particularly rapid expansion of mRNA products and personalized cancer vaccines. He argues that government research funding, grants, advance-purchase agreements and liability protections reduce commercial risk for pharmaceutical manufacturers while taxpayers assume part of the financial burden. The article also points to investments by large institutional shareholders and organizations such as the Coalition for Epidemic Preparedness Innovations as evidence of the extensive financial infrastructure surrounding vaccine development. Bryant goes considerably beyond documenting these investments, arguing that financial incentives can create demand for expensive treatments, influence medical consensus and encourage governments to protect private pharmaceutical interests. Those conclusions represent the author’s interpretation and are not established merely by the existence of public-private partnerships or institutional investment. Similarly, the article’s suggestion that Kennedy’s targeted PREP Act declaration could represent the beginning of a broader strategy to protect future mRNA products is presented as a warning rather than evidence of a documented federal plan. The central factual point is that an extensive mRNA research and commercialization pipeline does exist and extends well beyond COVID-19 vaccines. Bryant’s broader argument is that the public should scrutinize not only the safety and effectiveness of individual products but also the government funding, liability protections, investment incentives and regulatory structures supporting their development.
Special Guests: Julie Lapidus
Julie Lapidus, MSc, MSc, LMT is an author and the founder of Autism Evolution and Santara Wellness. She has been researching the top innovations in brain health and autism for sixteen years. She holds two Master of Science degrees and previously served as a director at an integrative behavioral health facility.
Goodbye, Antidepressants? Cutting Back On Processed Food Could Relieve Depression Adults with long-standing depression experienced substantial reductions in depression and anxiety symptoms while following a diet sharply reduced in ultra-processed foods, according to a small pilot crossover trial led by researchers at the University of California, San Francisco and published in JAMA Psychiatry. The study enrolled 20 adults ages 18 to 80 who had a primary diagnosis of depression, regularly consumed substantial amounts of ultra-processed food and also had metabolic concerns. All participants had high body weight and roughly half had high blood pressure. Nineteen completed the study, with an average age of approximately 44, 70% female, and an average history of depression approaching 13 years. Nearly two-thirds were taking at least one psychiatric medication and close to half were receiving therapy. Importantly, participants agreed not to change their medications, psychotherapy, exercise or sleep routines during the experiment. Researchers used a randomized crossover design in which each participant experienced both their normal diet and a period of substantially reduced ultra-processed food consumption, allowing participants to serve as their own comparisons. Adherence measurements indicated a dramatic dietary change, with ultra-processed-food screening scores falling from approximately 10 at baseline to 1.4 during the intervention. Depression scores dropped from an average baseline of 21.6 to approximately 8 during the low-ultra-processed-food period, compared with approximately 19 while participants followed their regular diets. Anxiety scores also declined substantially during the dietary intervention, and no adverse events were reported. Participants generally rated the intervention as useful, although many found maintaining the dietary changes difficult. Researchers do not yet know why the improvement occurred. Potential explanations include reductions in sugar, fat or overall calories, removal of preservatives or other additives, or broader nutritional changes resulting from replacing ultra-processed foods with less processed alternatives. The findings also cannot establish that ultra-processed foods cause depression or that eliminating them constitutes a treatment for depression. The trial was extremely small, participants knew which diet they were following, dietary intake was self-reported, and improvement in depression and anxiety was an exploratory outcome rather than the study’s primary endpoint. The researchers therefore describe the findings as hypothesis-generating rather than definitive. Nevertheless, the magnitude of the observed symptom changes among people with chronic depression, including many already receiving medication or psychotherapy, provides a basis for larger controlled trials designed specifically to determine whether reducing ultra-processed food can produce reproducible improvements in depression and anxiety and, if so, which dietary changes are responsible.
Question of The Day!
I’ve been trying to order Alta Silica X. Is there a story behind it’s disappearance? It’s out of stock everywhere. Been using it for many years. Any suggestions for a replacement?
Thank you
Patsy






